Header image

Optimising biologics manufacturing: Navigating outsourcing strategies and partner selection

Tracks
Track 1
Thursday, October 31, 2024
3:35 PM - 4:20 PM

Details

In the rapidly evolving field of biologics manufacturing, optimising outsourcing strategies and selecting the right partners are critical decisions that directly influence operational efficiency and product quality. This panel will bring together industry leaders to discuss the challenges and opportunities in outsourcing biologics manufacturing. The discussion will focus on effective strategies for streamlining outsourcing processes, from initial decision-making to long-term partnership management. Panellists will share practical examples and best practices that have proven successful in real-world scenarios, offering insights into how companies can enhance their biologics manufacturing operations. Key considerations for identifying and engaging with the most suitable outsourcing partners will be addressed, including technological capabilities, regulatory compliance, and cultural alignment. Attendees will gain valuable, actionable insights that can be applied to their own operations. The interactive format of the discussion will encourage audience participation, providing a platform for exploring diverse perspectives and solutions to common challenges in the field.


Speaker

Agenda Item Image
Dr. Kym Baker
General Manager, Brisbane
Thermo Fisher Scientific

Chair

Agenda Item Image
Ms Tertia Dex
Chief Manufacturing & Development Officer
HaemaLogiX

Panellist

Agenda Item Image
Ben Hughes
Director of Strategic Development
Therapeutic Innovation Australia

Panellist

Dr. Hywel Williams
Associate Director
CSL Ltd

Panellist

loading